Metraipolis › archive › dc_db76a27de220
Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal — Europe PMC PMID:17543114
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/17543114
- DOI
- 10.1186/1743-8462-4-9
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T08:10:41.800Z
- SHA-256 of the archived text
428d33199f293485549d5be55a593dad06abc89fd39a33075f1ebadc98803228- Stable URL of this page
https://metraipolis.com/documento/dc_db76a27de220
How to cite
Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal — Europe PMC PMID:17543114 — Europe PMC (en), https://europepmc.org/article/MED/17543114 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_db76a27de220 (Metraipolis archive dc_db76a27de220, sha256 428d33199f293485549d5be55a593dad06abc89fd39a33075f1ebadc98803228)
BibTeX
@misc{dcdb76a27de220,
title = {Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal — Europe PMC PMID:17543114},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/17543114},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_db76a27de220; sha256 428d33199f293485549d5be55a593dad06abc89fd39a33075f1ebadc98803228},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/17543114. Agents can read the archived copy with the MCP tool read_document.